Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
04/2002
04/04/2002US20020040144 For therapy of thrombotic disease, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury
04/04/2002US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity
04/04/2002US20020040002 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
04/04/2002US20020039998 Administering to human therapeutically effective amount of a combination of drug which is metabolized by cytochrome p450 monooxygenase or pharmaceutically acceptable salt thereof and ritonavir
04/04/2002US20020039767 Batch processing using nucleophilic compound
04/04/2002DE10044353A1 Unkompetitive Inhibitoren der Helikase-Primase Uncompetitive inhibitors of the helicase-primase
04/04/2002CA2426117A1 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
04/03/2002EP1193255A1 Heterocyclic compounds and medicinal use thereof
04/03/2002EP1193254A1 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method of using the same
04/03/2002EP1193250A1 Phenyl sulfamate derivatives
04/03/2002EP1192144A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
04/03/2002EP1192143A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits
04/03/2002EP1192137A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY
04/03/2002EP1192135A2 Serine protease inhibitors
04/03/2002EP1192133A1 N-cyclopentyl modulators of chemokine receptor activity
04/03/2002EP1192132A2 Serine protease inhibitors
04/03/2002EP0854872B1 Process for the preparation of a disubstituted thiazole
04/02/2002US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
04/02/2002US6365747 Method for the preparation of citalopram
04/02/2002US6365609 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
04/02/2002US6365607 Thiazolidinedione and oxazolidinedione compounds for treatment of diabetic anemia, edema, and anorexia
04/02/2002US6365579 Nitrate esters and their use for neurological conditions
04/02/2002US6365335 Sensitivity and decreased in residual color
04/02/2002US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
03/2002
03/28/2002WO2002024689A1 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis
03/28/2002WO2002024636A2 N-acylsulfonamide apoptosis promoters
03/28/2002WO2002024635A2 Aminoalcohol derivatives
03/28/2002WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
03/28/2002WO2002024200A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor
03/28/2002WO2001083434A3 P-(sulfonyl)-aryl and heteroaryls amines
03/28/2002WO2001064676A3 INHIBITORS OF p38-α KINASE
03/28/2002WO2001007405A3 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
03/28/2002US20020038034 Intermediates for the preparation of 2-imidazolin-5-ones
03/28/2002US20020037918 1-(aryl)-4-methyl-11-(hetrocycle)undeca-4,6,10-trien-1-ol for example; anticancer treatment, inhibit tubulin polymerization, inhibit binding of colchicine to tubulin, antiproliferative agents
03/28/2002US20020037911 Arylthiazolidinedione derivatives
03/28/2002US20020037910 Novel anilide compounds and pharmaceutical compositions comprising them
03/28/2002US20020037901 5-((2,4-bis-(4-methylphenylmethoxy)phenyl)methylene)-4-oxo-2-thioxo-3 -thiazolidineacetic acid, for example; treatment and prophylaxis of tumors and tumor metastasis
03/28/2002US20020037896 Bicyclic compounds
03/28/2002US20020037885 Therapeutic compounds
03/28/2002DE10038436A1 New 5-acceptor-functionalized 2-diarylamino thiophene or thiazole derivatives, especially useful for making organic light-emitting diodes
03/28/2002CA2423156A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor
03/27/2002EP1191611A2 Piezoelectric element and process for production thereof
03/27/2002EP1191526A2 Optical recording media
03/27/2002EP1191106A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren
03/27/2002EP1191019A1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
03/27/2002EP1189929A2 Factor viia inhibitors
03/27/2002EP1189895A1 Thiazole and oxazole derivatives and their pharmaceutical use
03/27/2002EP1189894A1 Thiazolidine carboxylic acid derivatives and their use in the treatment of cancer
03/27/2002EP1189612A1 Vla-4 inhibitor compounds
03/27/2002CN1342137A N2 phenylamidine derivatives
03/27/2002CN1341594A Substituted pyrrolidone, thiazolidone or oxazolidone as herbicide
03/27/2002CN1341593A Proteinase inhibitor
03/27/2002CN1341592A Proteinase inhibitor
03/27/2002CN1341590A Proteinase inhibitor
03/27/2002CN1341588A Intermediate product for preparing substituted 2,4-thiazolidine diketone derivative
03/26/2002US6362371 β2- adrenergic receptor agonists
03/26/2002US6362369 Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
03/26/2002US6362231 Calcium receptor active compounds
03/26/2002US6362230 Alzheimer's disease
03/26/2002US6362212 Oxime derivative and bactericide containing the same as active ingredient
03/26/2002US6362208 Anilide compounds and drugs containing the same
03/26/2002US6362205 For treating central nervous system disorders, cardiovascular system disorders, pulmonary system disorders, gastrointestinal system disorders, and endocrinologic system disorders
03/26/2002US6362138 Wear and oxidation resistance; for internal combustion engines
03/21/2002WO2002022612A1 Thiazolidine derivatives and its use as antifungal agent
03/21/2002WO2002022591A1 Process for resolution of 2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole and compounds therefor
03/21/2002WO2002022590A1 Process for preparation of 2-amino-6-(alkyl) amino-4,5,6,7-tetrahydrobenzothiazoles
03/21/2002WO2002022581A1 Nitrogen-containing compounds and their use as glycine transport inhibitors
03/21/2002WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs
03/21/2002WO2002021938A1 Compositions for enhancing or improving the flavor of foods or drinks and method of enhancing or improving the flavor of foods or drinks by using the same
03/21/2002WO2001077091A3 Ns5b hcv polymerase inhibitors
03/21/2002WO2001034135A3 Oncolytic combinations for the treatment of cancer
03/21/2002WO2001014372A3 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
03/21/2002US20020035267 Tetrazolyl-phenyl acetamide glucokinase activators
03/21/2002US20020035266 Tetrazolyl-phenyl acetamide glucokinase activators
03/21/2002US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors
03/21/2002US20020035127 Phenylalanine derivatives
03/21/2002US20020034605 Recording layer uses an organic dye that has an absorption maximum at a wavelength longer than that of the writing light; records information by irradiating the recording layer with writing light to act on the dye to form a pit
03/21/2002DE10044328A1 New thiazole-5-sulfonamide derivatives useful as antiviral agents, especially for control of herpes simplex infections
03/21/2002CA2422044A1 Nitrogen-containing compounds and their use as glycine transport inhibitors
03/21/2002CA2357469A1 Process for producing non-proteinogenic l-amino acids by fermentation
03/20/2002EP1188752A1 Process for producing substituted alkylamine derivative
03/20/2002EP1188745A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
03/20/2002EP1187833A1 Method of producing nitroguanidine- and nitroenamine derivatives
03/20/2002EP1137415A4 Myt1 kinase inhibitors
03/20/2002CN1341110A Novel process of preparing a benzothiazolone compound
03/20/2002CN1341109A Polycyclic thiazole-2-ylides amines, process for the production thereof and their utilization as medicaments
03/20/2002CN1341108A Polycyclic thiazole systems and their utilization as anorectics
03/20/2002CN1341107A Polycyclic 2-amino-dihydrothiazole systems, process for the production thereof and their utilization as medicament
03/20/2002CN1081187C Inhibitors of prenuyl transferases
03/19/2002US6359141 1h-1,2,4-triazole compounds useful as antifungal agents
03/19/2002US6359140 Hydrogenation, halogenation, epoxidation, reduction of epoxide to alcohol
03/19/2002US6359134 Sulfonamide derivatives, their production and use
03/19/2002US6358993 Pharmaceutically active nitrogen ring compounds and methods of use thereof
03/19/2002US6358983 Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists
03/19/2002US6358942 Microbiocides and bactericides for treating grampositive, bacteroides, clostridium, mycobacterium, staphylococcus and streptococcus infections
03/19/2002US6358634 Nitrogen-containing heterocyclic compound, organic light-emitting device material and organic light-emitting device
03/19/2002CA2187110C Benzamide derivative, compositions containing said derivative and use thereof
03/14/2002WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
03/14/2002WO2002020500A2 Materials and methods to potentiate cancer treatment
03/14/2002WO2002020497A1 Compounds having anti-hepatitis c virus effect